touchLearning Activities
Education, Conference Coverage and Articles
Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our mini-series exploring non-clinical skills that can help you thrive in your clinical ...
Celebrating the next generation of innovators in infectious diseases Following the success of the 2025 Future Leaders, touchINFECTIOUS DISEASESÂ is delighted to launch nominations for the Future Leaders 2026 initiative. The infectious diseases landscape continues to evolve rapidly, driven by emerging pathogens, ...
Evaluating high-dose influenza vaccination strategies in older and immunocompromised populations At ESCMID Global 2026, Dr Anne Marie Reimer Jensen (Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR), Herlev and Gentofte Hospital, University of Copenhagen, Denmark) discussed findings from the FLUNITY-HD ...
Recent public health updates have renewed attention on hantavirus infections worldwide. Here, we examine what hantavirus is, where cases are being reported, the current evidence around transmission and risk, and the key considerations for clinicians based on guidance from international ...
International Society for Infectious Diseases provides a global perspective on surveillance, innovation and equity in infectious disease control Infectious diseases remain a defining global health challenge, shaped by rapid scientific advancement and persistent inequities in access to care, knowledge and ...
As antimicrobial resistance continues to threaten global health, interest is growing in alternative approaches to treating bacterial infections. At ESCMID 2026, Dr Ikechukwu Moses presented early research exploring bacteriophages against methicillin-resistant Staphylococcus pseudintermedius, an emerging zoonotic pathogen associated with companion animals. ...
At ESCMID Global 2026, Prof. Holly Seale (University of New South Wales in Sydney, Australia) reflected on how conversations around respiratory vaccination needs to evolve, particularly for older adults. While messaging has traditionally focused on hospitalization and mortality, emerging evidence highlights ...
At ESCMID Global 2026, Prof. Holly Seale (University of New South Wales in Sydney, Australia) emphasized the importance of bringing together clinical, behavioral, and public health expertise when preparing for future respiratory threats. As innovation accelerates across vaccines, diagnostics, therapeutics, and ...
At ESCMID Global 2026, recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young Investigator Award, Dr Sarah Delliere (Université Paris Cité, Paris, France) discussed the growing momentum behind medical mycology and the need to rethink how invasive fungal ...
At ESCMID Global 2026, Dr Rebecca Hull (Respiratory Medicine and Gastroenterology, School of Medicine, University of Dundee, UK) discussed emerging treatment strategies for chronic Pseudomonas aeruginosa infection in bronchiectasis. In this interview, Dr Hull explains why new non-antibiotic approaches are urgently ...
At ESCMID Global 2026, Dr Clark Russell (Clinical Lecturer, Infectious Diseases & Microbiology, University of Edinburgh, Scotland, UK) discussed the growing need to rethink how bacterial infections are treated. Recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young ...
At ESCMID 2026, Dr Jon Salmanton-Garcia (University of Cologne, Germany) discussed the growing challenge of viral infections in immunocompromised patients. He explores how transplantation, CAR-T therapy and newer immunosuppressive treatments are changing infectious risk profiles, and highlights important advances in diagnostics, ...
At ESCMID Global 2026, Dr Jon Salmanton-Garcia, postdoctoral researcher at the University of Cologne and Chair of the ESCMID Fungal Infection Study Group (EFISG), discussed the evolving landscape of invasive fungal infections. He highlighted advances in diagnostics, promising antifungal therapies in ...
Conflict, war and displacement are increasingly recognised as major drivers of antimicrobial resistance (AMR), creating conditions where infections spread rapidly and access to healthcare, diagnostics and effective treatment is severely disrupted. At ESCMID 2026, Prof. Souha Kanj (American University of Beirut ...
At ESCMID 2026, Dr Daniel Pan discusses his research into respiratory virus transmission, health inequalities and the development of new approaches to measuring individual infectiousness. Recognized as a touchINFECTIOUS DISEASES Future Leader 2026 and recipient of a Young Investigator Award, Dr Pan ...
Older adults remain at increased risk of severe influenza outcomes, including hospitalization, cardiovascular complications and death. At ESCMID 2026, Dr Filip S. Davidovski presented findings from a secondary analysis of the DANFLU-2 trial, exploring the effectiveness of high-dose versus standard-dose influenza ...
Phase III PRIOH data suggest pritelivir could offer a new oral treatment option for immunocompromised patients with refractory herpes simplex virus, delivering improved lesion healing over investigator’s choice therapy. Refractory herpes simplex virus (HSV) infection remains a significant challenge ...
touchINFECTIOUS DISEASES
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
